WASHINGTON -- Researchers made a strong case that earlier was better when it comes to catheter ablation of ventricular tachycardias (VTs) in people with implantable cardiac defibrillators (ICDs).
VIENNA, AUSTRIA — Perhaps another good reason to ensure optimal medical therapy (OMT) before implanting an implantable cardioverter defibrillator (ICD): the risk of heart-failure decompensation is ...
The overall primary composite endpoint of inappropriate shocks and complications came out nearly identical (HR 0.99, 95% CI 0.71-1.39, P=0.01 for noninferiority) over a median 4 years in the ...
Please provide your email address to receive an email when new articles are posted on . Among patients who received implantable cardioverter defibrillator therapy, a subcutaneous vs. transvenous ...
Implantable cardioverter-defibrillators (ICDs) reduce mortality in patients with increased risk of sudden cardiac death, but use of these devices has been limited by complications with the ...
In a typical population of patients requiring implantable cardioverter-defibrillator (ICD) therapy without pacing, mostly for the primary prevention of sudden cardiac death, a subcutaneous ICD (S-ICD; ...
(HealthDay News) — For patients with cardiomyopathy, use of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) is associated with significantly lower incidence of ...
SAN FRANCISCO, CA—The subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) prevents most of the major lead-related complications seen with a transvenous system, the ATLAS ...
(RTTNews) - Boston Scientific (BSX) reported the final results from the UNTOUCHED study of the EMBLEM Subcutaneous Implantable Defibrillator, or S-ICD, System, an approved implantable defibrillator ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback